Search Login Register

Glycogen Storage Disease Type IIb Summary

23 relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and MENTAL RETARDATION. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.

Also Known As: Danon Disease; Glycogen Storage Disease IIb; Vacuolar Cardiomyopathy and Myopathy, X-linked; X-Linked Vacuolar Cardiomyopathy and Myopathy; Disease, Danon Show All >>

Key Drugs and Agents for Glycogen Storage Disease Type IIb

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. alpha-Glucosidases (Acid Maltase) : 10 results : IBA
  2. Lysosomal-Associated Membrane Protein 2 : 3 results : IBA
  3. Membrane Proteins (Integral Membrane Proteins) : 3 results : IBA
  4. Triad : 2 results : FDA 1
  5. RNA Splice Sites : 1 result : IBA
  6. Retinaldehyde (Retinal) : 1 result : IBA
  7. Membrane Glycoproteins (Membrane Glycoprotein) : 1 result : IBA
  8. Glycogen : 1 result : IBA
  9. DNA (Deoxyribonucleic Acid) : 1 result : IBA
  10. lysosomal proteins : 1 result : IBA

Diseases Related to Glycogen Storage Disease Type IIb

  1. Muscular Diseases (Myopathy)
  2. Glycogen Storage Disease (Glycogenosis)
  3. Mental Retardation (Idiocy)
  4. Cardiomyopathies (Cardiomyopathy)
  5. Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)
Show All >>

Key Therapies for Glycogen Storage Disease Type IIb

Efficacy Chart >>
  1. Heart Transplantation (Grafting, Heart) : 1 study in 4 results

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.